TTO News

Any Target, Every Time - How molecular “matchmaking” could pave the way for drug development to target the 85% of molecules considered undruggable., November 28, 2023

Lucid Diagnostics Announces PREVENT and PREVENT-FF Registries of EsoGuard® Esophageal Precancer Detection, October 31, 2023

NervGen Pharma Receives Fast Track Designation for NVG-291 for the Treatment of Individuals with Spinal Cord Injury, October 23, 2023

NervGen Pharma Announces First Subject Dosed in Landmark Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury, September 25, 2023

When a Network Matters! Functional iPSC-derived Endothelial Cells Finally Arrive
--Bioinformant, September 18, 2023

‘Great news for patients:’ Breathing device from UH, CWRU to help more paralyzed patients, July 25, 2023

Two NE Ohio startups land Ohio Third Frontier grants
--Crain's Cleveland Business, July 11, 2023

Lucid Diagnostics and Collaborators Present New EsoGuard® and EsoCheck® Data at Digestive Disease Week® (DDW) 2023 Conference
--PAVmed, May 11, 2023

Biomarkers and Balloons Help in the Fight Against Esophageal Cancer
--AUTM, April 21, 2023

Lucid Diagnostics Reports Publication of Future Effective Foundational Local Coverage Determination by Medicare Administrative Contractor Noridian Healthcare Solutions
-PAVmed, April 18, 2023

NervGen Pharma Presenting Phase 1b/2a Study Design at American Spinal Injury Association 50th Annual Scientific Meeting
--NervGen, April 13, 2023

NervGen Pharma Reports 2022 Year End Results and Provides Operational Update Including Plans to Initiate Phase 1b/2a Clinical Trial of Proprietary NVG-291 in Q3 2023
--NervGen, March 30, 2023

Biohm partners with Life Extension to design targeted microbiome supplements
--NutraIngredients USA, March 16, 2023

CWRU creates company to market its HoloAnatomy software that teaches cadaver-free anatomy, March 15, 2023

Case Western Reserve University completes exclusive license agreement with Atlanta-based RORA Biologics Inc. for cancer and HIV therapy technologies
--CWRU Daily, March 8, 2023

BIOHM Probiotic Products Gain Investment from Valley Growth Ventures
--The Business Journal Daily, March 8, 2023

Case Western Reserve University completes exclusive license agreement with Atlanta-based RORA Biologics Inc. for cancer and HIV therapy technologies
--CWRU Daily February 23, 2023

CWRU reaches international licensing deal with Atlanta company
--Crain's Cleveland Business, February 23, 2023

Lucid Diagnostics Holds First #CheckYourFoodTube Precancer Testing Event
--PAVmed, February 15, 2023

National Academy of Inventors names eight Case Western Reserve University researchers to 2023 class of senior members
--CWRU Daily, February 14, 2023

NervGen Pharma Announces Completion of Dosing of All Subjects in Phase 1 Clinical Trial of Proprietary Drug Candidate NVG-291

--NervGen, February 14, 2023

Bringing ideas to market: CWRU researchers turn discoveries into inventions
--CWRU Daily, February 13, 2023

St. Joseph students studying anatomy in virtual reality
--Fox 8 WJW, February 7, 2023

This Week In XR: $18 Million For Gemba VR Training, Dreamscape Learn Spins Off With $20 Million
--Forbes, January 27, 2023

$578 million for Greater Cleveland’s startups: These 23 companies raised the most cash in 2022
--Cleveland Plain Dealer, January 26, 2023

New company from Case Western Reserve University helps medical students learn anatomy through holographic imagery
--Ideastream Public Media, January 26, 2023

Making blood in the lab: Facing donor shortages and storage limitations, researchers are developing synthetic red blood cells, platelets, and plasma and combining them into artificial blood.
--Drug Discovery and Development, January 18, 2023

Case Western Reserve University launches Ilumis: Startup to accelerate and scale adoption of pioneering HoloAnatomy software to transform the way students learn human anatomy
--CWRU Daily, January 17, 2023

Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
--BusinessWire, December 8, 2022

Researchers Markowitz, Tyler elected fellows for 2022 class of National Academy of Inventors
--CWRU Daily, December 8, 2022

Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
--BusinessWire, December 1, 2022

Exclusive license agreement with Case Western Reserve University for Core-NK platform
--Chimeric Therapeutics, November 21, 2022

Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
--PAVmed, December 1, 2022

Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
--PAVmed, December 8, 2022

Researchers Markowitz, Tyler elected fellows for 2022 class of National Academy of Inventors
-CWRU Daily, December 8, 2022

Case Western Reserve University receives $1M state grant for technology start-up fund
--CWRU Daily, November 21, 2022

Third Frontier Provides Funds to Accelerate Innovation
--Ohio Department of Development, October 18, 2022

NervGen Pharma Receives FDA Authorization to Expand Enrollment of Males and Premenopausal Females in Phase 1 Clinical Trial of NervGen's NVG-291
--NervGen, October 25, 2022

A ‘game changer’ for people with sickle cell disease: Case Western Reserve University researcher, company, collaborating to develop blood test measuring the effects, potency of new gene therapies for sickle cell disease
--CWRU Daily, September 14, 2022

Top faculty to be honored during CWRU’s inaugural Innovation Week
--CWRU Daily, September 8, 2022

An inventive spirit, an impressive ranking
--CWRU Daily, September 8, 2022

A ‘game changer’ for people with sickle cell disease
--CWRU Daily, September 9, 2022

Folio Photonics Announces Breakthrough Multi-Layer Optical Disc Storage Technology to Enable Industry-Disruptive Cost, Cybersecurity and Sustainability Benefits
--Folio Photonics, August 30, 2022

Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio
--PAVmed, August 11, 2022

NervGen Pharma Reports Second Quarter 2022 Results and Provides Corporate Update
--NervGen, August 10, 2022

Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies
--Lucid Diagnostics, August 4, 2022

NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University
--BusinessWire, August 3, 2022

NervGen Presenting Study Design for Upcoming Phase 1b/2a in Alzheimer's Disease at the 2022 Alzheimer's Association International Conference
--NervGen, August 2, 2022

Lucid Diagnostics’ Laboratory Executes Four New Participating Provider Agreements
--PAVmed, August 2, 2022

NervGen Pharma Closes US$15MM Private Placement and Appoints Dr. Adam Rogers to Board of Directors
--NerGen, July 14, 2022

RAD adds brain tumor technology to portfolio
--Radiopharm Theranostics, June 9, 2022

Case Western Reserve University signs license agreement to bring artificial intelligence breakthroughs closer to cancer patient care
--CWRU Daily, May 25, 2022

Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University
--AccessWire, May 12, 2022

Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
--PAVmed, May 9, 2022

Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination
--PAVmed, April 4, 2022

NervGen Presenting Interim Phase 1 Clinical Trial Data for NVG-291 at the 2022 American Academy of Neurology Annual Meeting
--NervGen, March 31, 2022

PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
--PAVmed, March 24, 2022

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
--PAVmed, March 23, 2022

NervGen Pharma Receives Approval from Safety Review Committee to Proceed to Second Cohort in Multiple Ascending Dose Portion of Phase 1 Clinical Trial of NVG-291
--NervGen, March 15, 2022

PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth
--PAVmed, March 3, 2022

Three Case Western Reserve University faculty elected as 2022 Senior Members of National Academy of Inventors
--CWRU Daily, February 11, 2022

Case Western Reserve University grants exclusive license to Ionis Pharmaceuticals to advance antisense therapy for Pelizaeus-Merzbacher disease
--CWRU Daily, January 27, 2022

Road-painting robot created in Northeast Ohio could save lives
--News 5 Cleveland, January 21, 2022

Case Western Reserve University partners with Produce Perks Midwest, expanding nutrition-incentive technology at farmers’ markets
--CWRU Daily, January 20, 2022

CWRU On Track

--Crain's Cleveland Business, January 20, 2022

CWRU inks licensing deal to commercialize an imaging agent to aid in brain tumor surgery
--Crain's Cleveland Business, January 19, 2021

Cleveland-based RoadPrintz Inc. receives $1M from National Science Foundation to advance mobile robotic pavement-marking system

--CWRU Daily, January 5, 2022

NervGen Pharma Receives Ethics Approval to Initiate Phase 1 Clinical Trial for NVG-291
--NervGen, December 22, 2021

Zheng-Rong Lu elected fellow of National Academy of Inventors
--CWRU Daily, December 22, 2021

PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
--PAVmed, December 1, 2021

Chimeric Transforms Portfolio With a Clinically Validated, Off the Shelf, Natural Killer (NK) Cell Platform
--Global NewsWire, November 30, 2021

NervGen Pharma Corp. Closes Non-Brokered Private Placement
--NervGen, November 29, 2021

First Point-of-Care Test for Serious Hemoglobin Disorder, Beta Thalassemia, Provides New Weapon for the Front Lines of Healthcare Worldwide
--Hemex Health, November 24, 2021

NervGen Pharma Reports Third Quarter 2021 Results
--NervGen, November 18, 2021

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
--Luicd Diagnostics, November 11, 2021

NervGen Presents Additional Phase 1 Clinical Trial Data for NVG-291 at Neuroscience 2021
--NervGen, November 4, 2021

Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award
--Lucid Diagnostics, October 28, 2021

Case-Coulter Translational Research Partnership, with support provided by JobsOhio for the Cleveland Innovation District, awards $1.9 million in funding and support for promising biomedical engineering university technologies
--CWRU Daily, October 20, 2021

NervGen Presents Interim Phase 1 Clinical Trial Data for NVG-291 at the American Neurological Association 14th Annual Meeting
--NervGen, October 18, 2021

Lucid Diagnostics Announces Pricing of Initial Public Offering
--PAVmed, October 13, 2021

Peak Nanosystems raises $25 million from Squadron Capital
--Crain's Cleveland Business, October 11, 2021

NervGen Pharma Partners with Imeka to Use Novel Neuroimaging Technology in Clinical Trails
--NervGen Pharma, September 27th 2021

Lucid Diagnostics, a medtech company with ties to Case Western Reserve University, plans to go public
--Crain's Cleveland, September 27, 2021

PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
--PAVmed, September 23, 2023

Lucid Diagnostics prepares to leave the PAVmed nest with $57M IPO filing
--Fierce Biotech, September 23, 2021

PAVmed: A Small Cap Puts Its Streamlined Development Model to the Test, August 19, 2020

PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers
--Business Wire, August 10, 2021

Nervgen Pharma and Massachusetts General Hospital Collaborate on Preclinical Studies in Alzheimer’s Disease
--Business Insider, August 9, 2021

PAVmed: A Small Cap Puts Its Streamlined Development Model to the Test
--MedTech Strategist, August 2, 2021

Breakthrough Device ClotChip Moves Forward Toward Production
--PRNewswire, July 22, 2021

Case Western Reserve University Licenses Rapid Malaria, Hemoglobin Disorder Tests
--AUTM, July 16, 2021

Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System
--Neuros Medical, June 29, 2021

Presidio Medical Announces New Executive Appointment
--BusinessWire, June 28, 2020

NervGen Pharma: A “Blockbuster Drug” in the Making?
--Stockhouse, June 28, 2021

Third Frontier awards more than $9 million in funding for Northeast Ohio
--TechOhio, Junwe 24, 2021

Case Western Reserve ranks 21st in the world for U.S. utility patents
--CWRU Daily, June 15, 2021

PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test
--PAVmed, June 10, 2021

NervGen Pharma Enters into Research Agreement with Sylics to Study NVG-291 in Alzheimer’s Disease Models
--NervGen, June 10, 2021

MedLumics Closes Upsized (21.7M USD) Financing Round and Appoints New Chairman
--MedLumics, May 28, 2021

PAVmed  Subsidiary  Lucid  Diagnostics Receives  CE  Mark  Certification  for  its EsoCheck®  Esophageal  Cell  Collection Device
--PAVmed, May 26, 2021

NervGen Pharma Reports First Quarter 2021 Results
--NervGen, May 20, 2021

A Quiet Student Startup Bursts Into the Big Time as Path Robotics Attracts $56 Million In New Investment
--CWRU Daily, May 7, 2021

NervGen Pharma Announces First Subject Dosed in Phase 1 Clinical Trial of NVG-29
--NervGen, May 6, 2021

Case Western Reserve University-Developed Imaging Agent for MRI Prostate Cancer Detection Gets FDA Approval for Safety Trails, Set to Begin This Month in Columbus
--CWRU Daily, May 5, 2021

Ohio Third Frontier Commission bolsters Case Western Reserve University startup funding
--CWRU Daily, April 29, 2021

FDA Approves Tumor-Based MRI Contrast Agent for Prostate Cancer Detection
--Diagnostic Imagining, April 25, 2021

NervGen Pharma Announces Appointment of Pharma Veteran Dr. Daniel Mikol as Chief Medical Officer
--NervGen Pharma, April 22, 2021

First Clinical Trials Set for MRI Cancer Detection
--Eurek Alert, April 22, 2021

CWRU Atelerix Sign Option License to Develop Therapeutic Approach to Opioid Crisis
--Crain's Cleveland, April 20, 2021

Team players: Cleveland Innovation District is a group effort for local healthcare investment

--FreshWater Cleveland, April 22, 2021

Cardialen Announces Positive Results From Low-Voltage MultiPulse Therapy to Terminate Atrial Fibrillation
--Business Wire, April 13, 2021

Journey to multi-million dollar Amgen acquisition required curiosity, collaboration and commercial expertise
--CWRU Daily, April 8, 2021

Case Western Reserve University biotech startup Rodeo Therapeutics Corp. sold to Amgen Inc.
--CWRU Daily, March 31, 2021

Amgen to Acquire Rodeo Therapeutics Corporation
--PRNewswire, March 30, 2021

Preclinical Program Targeting 15-PGDH has Potential use in Broad Range of Therapeutic Applications Including Inflammatory Disease Indications
--The PharmaLetter, March 30, 2021

Equalize 2021 Pitchers Announced
--Equalize, February 18, 2021)

NervGen Pharma Receives Orphan Designation from the European Medicines Agency for NVG-291 for the Treatment of Spinal Cord Injury

--NervGen March 8, 2021

NervGen Pharma Provides Regulatory Update on Development Program for NVG-291

--NervGen, March 2, 2021

PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results

--PAVmed February 22, 2021

Rohan Akolkar Elected Senior Member of National Academy of Inventors

--CWRU Daily February 11, 2021

NervGen Pharma Adds Alzheimer’s Disease Patient Cohort to its Phase 1 Clinical Trial Program

-NervGen January 27, 2021

NervGen’s 2020 in Review and the Plan Ahead

--NervGen January 11, 2021

Neuros Medical Announces Key Milestones in the Quest Pivotal Clinical Study for Chronic Post-Amputation Pain
--Neuros Medical January 06, 2021

Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain
--Neuros Medical January 06, 2021

Tevard, Zogenix Partner to Advance Gene Therapies for Genetic Epilepsies
--Dravet Syndrome News January 05, 2021

NervGen to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
--NervGen Pharma January 5, 2021

Global Health Breakthroughs – other than for COVID-19 in 2020
--Devex December 22, 2020

NervGen Pharma Engages CRO for Phase 1 Clinical Trial

--NervGen December 15, 2020

Case-Coulter Translational Research Partnership Awards $1.1 Million in Funding and Support for Promising Biomedical Engineering University Technologies
--CWRU Daily December 14, 2020

Case Western Reserve University biomedical engineering leaders Scott Bruder, Anant Madabhushi honored for ‘spirit of innovation’

--CWRU Daily December 8, 2020

Tevard Biosciences, Zogenix partner on tRNA-based Gene Therapies
--The Science Advisory Board December 04, 2020

Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies
--Tevard Biosciences December 3, 2020

NervGen Pharma Reports Third Quarter 2020 Results and Provides Operational Update
--NervGen Pharma November 19, 2020

Neuros Medical is Raising $42.8 Million
--Crain’s Cleveland Business November 11, 2020

Team of Case Western Reserve University Researchers to Study Plastic Recycling Thanks to $2.5M Grant
--News 5 Cleveland November 10, 2020

Trailhead Biosystems Raises $6.6 Million in Series A Financing
--Trailhead Biosystems Inc. November 10, 2020

NervGen Retains Dr. George Perry to Advise on Alzheimer’s Disease Program
--NervGen Pharma November 10, 2020

NervGen Pharma Engages Dr. Michael Davis, Former Director of the U.S. Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non-dilutive Funding Sources for NVG-291

--NervGen October 19, 2020

VA, CWRU Researchers Create Smart Bandage to Improve Wound Care for Veterans
--News 5 Cleveland October 12, 2020

HEMEX Health’s “Gazelle” earns third prize in NIH Technology Accelerator Challenge

--CWRU Daily October 9, 2020

Diaphragm Pacing can Enhance Recovery and Weaning from Mechanical Ventilation (MV) in Cardiac Surgery

--PR Newswire October 1, 2020

NervGen Pharma Provides Company Update and Announces Results of Annual General Meeting of Shareholders

--NervGen October 1, 2020

Mosaic ImmunoEngineering Inc. signs license-option to advance novel immunotherapy to treat cancer and infectious diseases

--CWRU Daily August 31, 2020

NervGen Pharma Reports Second Quarter 2020 Results Phase 1 Clinical Study Remains on Track for Q4 2020

--NervGen August 21, 2020

PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update

--Global NewsWire August 18, 2020

Scientists work to freeze-dry synthetic platelets

--CWRU Daily August 12, 2020

Umut Gurkan elected senior member of National Academy of Inventors

--CWRU Daily August 11, 2020

NervGen Pharma Corp. Completes $6.45 Million Public Offering

--NervGen August 10, 2020

PAVmed Secures $7 Million Convertible Note Financing

--Global NewsWire August 6, 2020

--NervGen July 27, 2020

Case Western and VA partner with Pennsylvania start-up to commercialize adjustable walker

--Tech Transfer Central July 15, 2020

Presidio Medical Announces $30 Million Financing Round Led by Invus Opportunities

--Presidio July 14, 2020

LevelMed signs agreement to commercialize self-leveling walker

--TechLink July 13, 2020

Haima Therapeutics Receives Phase II TVSF Award from the State of Ohio to Develop its SynthoPlate Product for Veterinary Use

--Haima Therapeutics press release July 9, 2020

Luminary Therapeutics and Case Western Reserve University Enter Formal Collaboration for Development of BAFF CAR

--EIN Presswire July 7, 2020

Akouos Announces Closing of Initial Public Offering

--Globe NewsWire June 30, 2020

Third Frontier awards $2.4 million to Northeast Ohio universities and companies

--Crain's Cleveland Business June 29, 2020

Advancing Cutting-Edge Technology in Ohio: Third Frontier Accelerating New Ideas and Solutions

--Ohio Development Services Agency June 24, 2020

XaTek to develop rugged ClotChip for U.S. Navy

--PR Newswire June 23, 2020

CWRU researchers develop technology to recycle plastic waste from cars, planes, industry

--News 5 Cleveland June 23, 2020

NervGen Pharma to Collaborate on Chronic Spinal Cord Injury Study Sponsored by the State of Ohio

--NervGen Pharma press release June 22, 2020

CWRU completes license option with spinout company Edifice Analytics

--Crain's Cleveland Business June 19, 2020

New, Quick Test For Sickle Cell Disease Comes Online

--Ideastram June 19, 2020

Case Western Reserve Completes License Option with Spinout Company Edifice Analytics Inc

--CWRU Daily June 18, 2020

A New Weapon in the Fight Against Sickle Cell Disease

--CWRU Daily June 18, 2020

'Optimized for the underserved': A new diagnostic test built for low-income settings

--Devex June 17, 2020

Gazelle™ Diagnostic Platform, Designed for Low Resource Settings, Integrates Miniaturized Technologies with AI to Transform Disease Screening and Diagnosis

--Hemex Health press release June 16, 2020

Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor

--PAVmed June 15, 2020

PAVmed Subsidiary Lucid Diagnostics Receives Preliminary Payment Determination for EsoGuard Esophageal DNA Test

--GlobeNewswire June 11, 2020

Haima Therapeutics Licenses Synthetic Platelet Technology from Case Western Reserve University for Hemostatic Therapy

--CWRU Daily June 3, 2020

Top 100 Worldwide Universities Granted U.S. Utility Patents in 2019 Announced

National Academy of Investors June 2, 2020

New Technology Gives Patients Access to a 5-Minute, Office-Based Test to Identify Risk for Esophageal Cancer

--National Cancer Institute June 1, 2020

NervGen Pharma Reports First Quarter 2020 Results - Phase 1 Clinical Trial Remains on Track

--NervGen Pharma Corp. press release June 1, 2020

RoadPrintz Inc., with technology created at CWRU, secures additional funding to advance robotic street-painting vehicle

--CWRU Daily May 26, 2020

RoadPrintz and Case Western Reserve University Testing Robotic Pavement Marking Machine

--ForConstructionPros May 20, 2020

First successful field evaluation of new, one-minute haemozoin-based malaria diagnostic device

--Elsevier press release April 24, 2020

Medical Device Developed by CWRU/UH Researchers Wins 2020 Edison Award

--CWRU Daily April 23, 2020

Peak Nanosystems Raises $25mm Series C Round to Fund Acquisition and Expand Product Lines

--The Moore County News Press April 14, 2020

XaTek Inc. Receives FDA’s “Breakthrough Devices Designation” for CWRU-Licensed ClotChip Technology

--CWRU Daily April 2, 2020

PAVmed Subsidiary Lucid Diagnostics’ EsoCheck Esophageal Cell Collection Device Receives Prestigious Edison Best New Product Award

--GlobeNewswire April 2, 2020

First successful field evaluation of new, one-minute haemozoin-based malaria diagnostic device

--Elsevier press release April 2, 2020

XaTek Inc. Receives Key FDA Designation to Aid Commercialization of its ClotChip Device

--Crain's Cleveland Business March 3, 2020

U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test

--Globe Newswire February 11, 2020

Local Inventors Create Prototype That Can Make Painting Roads Safer, Less Expensive

--WJW FOX 8 News Cleveland January 29, 2020

CWRU Hopes a Local Company is on the Road to Producing a Safer, Faster Painting System

--Crain's Cleveland Business January 23, 2020

University’s HoloAnatomy Spreads to Other Campuses

--CWRU Daily January 22, 2020

CWRU and RoadPrintz Inc. Sign License Agreement to Advance Robotic Street-Painting Technology

--CWRU Daily January 21, 2020

Releasing the Handbrake on Endogenous Repair – An Alternative Approach to Treating Alzheimer’s Disease?

An interview with NervGen Pharma President and CEO, Paul Brennan

--Technology Networks January 13, 2020

PAVmed Subsidiary Lucid Diagnostics Announces Commercial Launch of EsoGuard Esophageal DNA Test

--Globe Newswire December 19, 2019

Pamela B. Davis—dean of Case Western Reserve University School of Medicine—named a Fellow of the National Academy of Inventors

--CWRU Daily December 3, 2019

PAVmed Reports Third Quarter 2019 Financial Results and Provides Business Update

--GlobalNewswire November 21, 2019

NervGen Pharma Receives Investment from Drug Manufacturing Partner - CSBio Invests US$1,5000,000 as Part of Manufacturing Contract for Clinical Trial Product

--NervGen Pharma November 18, 2019

Treating Usher Syndrome Hearing Loss - Researchers Develop Pioneering Gene Therapy Technology

--University Hospitals News November 13, 2019

Cleveland Heights Car Mechanic Finds a Much Cheaper Way to Paint Lines on Streets

--FreshWater Cleveland October 24, 2019

The World’s Most Innovative Universities 2019

--Reuters October 23, 2019

CollaMedix - A Biotech Startup Founded with Technology Invented at CWRU and UHCMC - Reaches Exclusive Licensing Agreement

--CWRU Daily October 16, 2019

Patent-Pending Probiotic Could Disrupt Crohn’s Disease Biofilms

--CWRU Daily September 30, 2019

Introducing xLab - Where Case Western Reserve Students Help Shape Digital Strategies for Established Companies

--CWRU Daily September 30, 2019

Folio Photonics Was Named One of the 10 Hottest Data Storage Startups of 2019

--Refinery Ventures September 27, 2019

CWRU and Akouos Sign Exclusive Licensing Agreement to Advance Development of Gene Therapy Technology as a Potential Treatment for a Type of Usher Syndrome

--CWRU Daily September 5, 2019

Swallowable Device to Detect Pre-cancerous Barrett's Esophagus Receives FDA 510(k) Clearance

--CWRU SOM September 5, 2019

Case Comprehensive Cancer Center Director Elected Senior Member of the National Academy of Inventors

--CWRU Daily August 13, 2019

Microsoft Quantum Algorithm Boosts Medical Imaging

--Fortune July 15, 2019

Case Western Reserve Spinout Company, Convelo Therapeutics, Partners with Genentech to Develop Medicines for Neurological Disorders

--CWRU Daily July 30, 2019

Case Western Reserve University Ranked 17th in "Top 100 Worldwide Universities Granted U.S. Utility Patents in 2018"

--CWRU Daily June 15, 2019

Folio Photonics of Solon Closes $8 Million Seed-Financing Round

Crain's Cleveland Business May 21, 2019

Developing and Commercializing Peptide Therapeutics for Nerve Regeneration- An Interview with NervGen Pharma

--RegMedNet May 15, 2019

NervGen Pharma Completes $10 Million Initial Public Offering; Shares to Commence Trading on TSX-V on March 15, 2019 – Symbol “NGEN”

--Investing News Network March 13, 219

How the Think[box] Makerspace Became the Epicenter of Innovation

-- Innovation & Tech Today February 1, 2019

Meet the Six Finalists for the University's $50,000 Startup Contest

-- CWRU Daily January 23, 2019

CWRU Receives Third-Straight $500,000 Technology Startup Fund Award from Ohio Third Frontier Commission

-- CWRU Daily January 16, 2019

PAVmed Provides Business Update

-- GlobalNewswire January 10, 2019

Refinery Fund I, LP Closes: Welcome Folio Photonics

-- Refinery Ventures Newsletter January 2019

Seattle Biotech Startup Raises $3.7M to Help the Body Regenerate Tissue

-- GeekWire December 13, 2018

The 10 Most Incredible Medical Breakthroughs of 2018

-- Prevention December 6, 2018

PAVmed Subsidiary Lucid Diagnostics Files 510(k) Submission with FDA for EsoCheck Cell Collection Device

-- GlobeNewswire November 29, 2018

PAVmed Reports Third Quarter 2018 Financial Results and Provides Business Update

-- GlobeNewswire November 15, 2018

EsoCheck Well Received at ACG Annual Meeting

-- PAVmed News November 13, 2018

Hemex Health Developing Malaria Detector with Navy Researchers in Peru

-- TechLink November 5, 2018

Sending Discoveries into the World

-- CWRU THINK Magazine Fall 2018 Issue

Road Map to the Heart

-- CWRU THINK Magazine Fall 2018 Issue

Blockland Backers Dream of a Cleveland Tech Mecca

-- WKSU News October 22, 2018

Haima Therapeutics, a CWRU Spinoff, Funded by Department of Defense

-- CWRU Daily October 19, 2018

CWRU Researchers Cure Drug-Resistant Infections without Antibiotics

-- CWRU School of Medicine October 17, 2018

Cleveland, Akron are Tech Patent Powers

-- Crain's Cleveland Business October 14, 2018

Reuters Top 100: The World's Most Innovative Universities - 2018

-- Reuters October 10, 2018

Cardialen Closes $17 Million Series B Financing for Heart Rhythm Therapy

-- Cardialen News October 10, 2018

CWRU, Engine Biosciences Sign Exclusive Option License for University-Based Technology to Treat Debilitating Neurodegenerative Diseases

-- CWRU Daily October 4, 2018

Using Mobile Technology to Fight Disease: Three Tips for Social Startups in the Developing World

-- NextBillion October 3, 2018

A SMART Idea: Point-of-Care Diagnostic for Sickle Cell Disease and Malaria

-- Medgadget October 1, 2018

I-Corps@Ohio Adds New Governance Board

-- ICorps@Ohio Augst 16, 2018

Nervgen Pharma Announces Granting Of US Patent For Breakthrough Nerve Regeneration Technology

-- August 10, 2018

USPTO Announces 2018 Patents for Humanity Winners

-- August 9, 2018

'Virtual' Energy Audits

-- CWRU Daily August 8, 2018

Convelo Therapeutics, founded on discoveries at Case Western Reserve, to develop regenerative medicines for neurological disorders 

-- CWRU Daily July 31, 2018

Mixed Reality: A Revolutionary Breakthrough in Teaching and Learning

-- EDUCAUSEreview July 30, 2018

New startup Convelo links old and new compounds to myelin repair in MS

-- FierceBiotech July 26, 2018

A New Roadmap for Repairing the Damage of Multiple Sclerosis 

-- CWRU Newscenter July 25, 2018

A New Milestone in Laboratory Grown Human Brain Tissue

-- CWRU Newscenter July 25, 2018

Convelo Therapeutics to Develop New Regenerative Medicines for Neurological Disease Characterized by Loss of Myelin

-- Business Wire July 25, 2018

Convelo Therapeutics, founded on discoveries made at Case Western Reserve University School of Medicine, launches publicly

-- Crain's Cleveland Business July 25, 2018

Case Western Reserve Enters Licensing Agreement with Canadian Company

-- Crain's Cleveland Business July 24, 2018

Case Western Reserve, NervGen sign license agreement to develop therapies for spinal-cord injury and other nerve-damage conditions

-- CWRU Daily July 24, 2018

Thermalin Announces: Additional Closing on $21M Series A Preferred Financing to Support its Cleveland-based R&D Team

-- July 21, 2018

Case Western Reserve start-up’s Series A brings $9.1M to develop test for blood clotting 

-- Tech Transfer Central July 18, 2018

NervGen Pharma Licenses Breakthrough Nerve Regeneration Technology From Case Western Reserve University

-- Press Release July 17, 2018

XaTek Inc. Raises $9.1 Million to Advance ClotChip, a Hand-held Device to Quickly Gauge Blood's Clotting Ability

-- Crain's Cleveland Business July 10, 2018

Case Western Among Top 100 Worldwide Universities Granted U.S. Utility Patents in 2017

-- CWRU Daily June 14, 2018

New CWRU, Haima Therapeutics' blood-clotting platelet simulators could save lives

-- June 7, 2018

Hemex Health and Partners Win Vodafone Foundation 2018 Wireless Innovation Contest

-- June 6, 2018

Case Western license out nanotechnology to treat bleeding complications

-- Crain's Cleveland Business June 6, 2018

Case Western Reserve and Haima Therapeutics sign option license to develop SynthoPlate

-- CWRU Daily June 4, 2018

Winners of the first round of 2018 CWRU Technology and Validation Start-Up Fund Program awards announced

-- CWRU Daily June 1, 2018

CWRU and Haima Therapeutics LLC Sign Option License to Develop SynthoPlate

-- Crain's Cleveland Business May 30, 2018

Case Western Reserve announces new partnership with Microsoft 

-- Crain's Cleveland Business May 18, 2018

Case Western Reserve University, Lucid Diagnostics Signs License Agreement to Commercialize Fast, Accurate Barrett's Esophagus Detector

-- CWRU Daily May 16, 2018

Lucid Diagnostics License Barrett's Esophagus Biomarker Tech from CWRU

-- Genomeweb May 14, 2018

PAVmed and Case Western Reserve University Finalize Definitive Licensing Agreement for Groundbreaking Esocheck Technology 

-- PAVmed May 14, 2018

First Round of 2018 CWRU Technology and Validation Start-Up Fund (CTP) Awards Announced

-- Press Release May 10, 2018

First Round of the 2018 Case Western Reserve University Technology and Validation Start-Up Fund Program (CTP) Awards Announced 

-- CWRU Tech Transfer Office Spring 2018

PAVmed Signs Letter of Intent with Case Western Reserve University to Commercialize Groundbreaking Esocheck Technology

-- Business Wire April 24, 2018

Four Case Western Reserve University medtech research projects selected for State of Ohio’s focused commercialization training

-- CWRU Daily April 20, 2018

Startup goes inside our blood, draws top pitching prize at new CWRU contest

-‌- CWRU Daily March 21, 2018

Business Oregon Announces Awards for Startups to Bring Concepts Closer to Market

-- Business Oregon March 14, 2018

Case Western Reserve University receives additional $500,000 state grant

-- CWRU Daily March 13, 2018

New angel investor network steers investment to startups associated with CWRU

-- CWRU Daily March 13, 2018

Case Students and Alum Will Pitch in the Inaugural Morgenthaler-Pavey Startup...

-- WKSU March 12, 2018

Peak Nano Optics Closes Minority Investment with L3 Technologies

-- Peak Nano February 28, 2018

L3 Invests in Nanotechnology Optics Company

--Square Space News February 28, 2018

Diagnosis: Biomarkers and balloons for the detection of Barrett oesophagus

-- Nature Reviews February 7, 2018

Biohm aims to bring balance to the gut

-- Crain's Cleveland Business February 3, 2018

Cleveland Foundation awards $1.75 million

-- CWRU Daily January 30, 2018

Cleveland Foundation awards $1.75 million (Cleveland Foundation News)

-- Cleveland Foundation January 30, 2018

Swallowable Balloon Device Detects Barett's Esophagus

-- Medscape January 22, 2018

Quick Test Could Spot Precursor to Esophageal Cancer

--U.S. News January 19, 2018

New York Car Care Product Maker Makes OC Home

-- Orange County Business Journal January 15, 2018

 Alevca Ocular

-- Tech Transfer Central January 10, 2018

Breakthrough brain cancer treatment moving forward at Cleveland State University

-- News 5 Cleveland January 9, 2018

10 Case Western Reserve University entrepreneurs to show at CES 2018

-- CWRU Daily January 8, 2018

Ohio's top technology licensing earners seek sustainability after blockbusters

-- Columbus Business First January 5, 2018

Alevca Ocular gains CWRU Technology Transfer licenses to develop....

-- CWRU Daily January 5, 2018

CWRU spots Alevca Ocular's potential

-- Global University Venturing January 4, 2018

Alevca Ocular secures licenses from CWRU for novel ophthalmological drugs

-- Crain's Cleveland Business January 3, 2018

‌‌‌CWRU Technology and Validation Start-Up Fund Program awards four new projects...

-- CWRU Daily December 22, 2017

Hemex Health Announces Close of $3M Seed Funding

-- December 18, 2017

NAI New Fellows Guide - Dr. Mark Griswold

-- NAI Fellows December 12, 2017

We'll Build An App For That

-- THINK Magazine Fall 2017

Case-Coulter Translational Research Partnership awards $1.1 million for...

-- CWRU Daily November 20, 2017

Cleveland-based Thermalin gets funding for diabetes research

-- November 7, 2017

Hemex Health Raises Over $600,000 Investment From Tie Global Angels

-- November 5, 2017

CWRU among best in the country for commercialization of research

-- CWRU Daily October 31, 2017

Case Western Reserve’s Paul Tesar selected to receive New York Stem Cell...

-- CWRU Daily October 24, 2017

What Does Insulin Smell Like?

-- October 11, 2017

Downtown universities outperform their suburban and rural counterparts

-- October 10, 2017

Hidden in plain sight: The oversized impact of downtown universities

-- October 2017

Putting precision care on the spot

-- Crain's Cleveland Business October 7, 2017

MedTech Firm Thermalin Raises $17.5 Million, Announces Partnership with Sanofi to Develop Insulin Therapies

--Crain's Cleveland Business September 28, 2017

MRI contrast agensivet locates and distinguishes aggressive slow growing...

-- CWRU Daily September 25, 2017

Aggressive Breast Cancer Identified Using New MRI Contrast Agent

--Genetic Engineering & Biotechnology News September 25, 2017

Ohio Third Frontier provides grants to two Cleveland tech startups

-- Crain's Cleveland Business September 15, 2017

Neuros Medical Appoints Tom Wilder as President and CEO

-- BusinessWire August 28, 2017

Case Western Reserve University Researchers Develop Therapeutic to Enhance Tissue Repair and Generation

--CWRU Daily August 22, 2017

Hemex Health Selects Tata Elxsi as the Product Design and Engineering Partner for its 'Lab-in-a-Box' -- a Point-of-care Diagnostic Platform

--CISION PR Newswire August 8, 2017

Neuros Medical Announces Closing of $20 Million Venture Financing

--BusinessWire August 7, 2017

OrthoPediatrics Corp. Launches New Pediatric Specific Clavicle Plates

--PR Web August 4, 2017

Intwine Connect Announces Strategic Distribution Agreement for North America with Arrow Electronics

--CISION PR Newswire July 26, 2017

Regenerative Medicine Start-Up Rodeo Therapeutics Raises $5.9M for Drugs to Regenerate Tissue

--GeekWire July 25, 2017

Second Round of CWRU Technology and Validation Start-Up Fund Program Awards Announced

-- CWRU Daily July 21, 2017 

CWRU, ICBM Medical Sign Agreement to Further Develop Technology to Provide Patient Screening and Monitoring

-- Crain's Cleveland Business June 9, 2017

Kent State, Case Western Reserve, University of Akron Finalists for National Entrepreneurship Awards May 17, 2017

CWRU Biomedical Engineers Win First Place in Collegiate Division at Medical Capital Innovation Competition

--CWRU Daily May 5, 2017

Four CWRU Medtech Research Projects Selected for Ohio's Focused Commercialization Training

--CWRU Daily April 10, 2017

Case Western Reserve and Q2 Pharma Partner to Develop Antivirulence Agents that Disarm Superbugs

--News Medical March 31, 2017

Micro-Leads Inc. and Case Western Reserve University School of Medicine Announce Two Exciting Milestones Amidst GSK Innovation Challenge

--BusinessWire January 10, 2017

Case Western Reserve University showcases ingenuity at CES 2016 

--CWRU Press Release December 28, 2015

Technology Transfer Office’s Arlicia Headd passes away

--CWRU Daily November 13, 2015

Vision Medicines Announces Exclusive Licensing Agreement with CWRU

--Visions Medicines News November 9, 2015--

CWRU Technology Transfer Office Wins Licensing Executives Society "Deals of Distinction" Award

--CWRU Think Magazine October 6, 2016--

Case-Coulter Translational Research Partnership awards $1 million in funding

--CWRU Think Magazine September 22, 2015--

 CWRU Ranked 82 in Reuter's 100 Most Innovative Universities

--Reuters, September 15, 2015--

Faculty-student team participating in summer cohort of research commercialization program

--CWRU Daily August 3, 2015--

CWRU signs option agreement with Wholesome Wave to launch FM Tracks app

--CWRU Daily July 20, 2015--

Red5 Pharmaceuticals attains exclusive license from CWRU

--CWRU Press Release July 10, 2015--

CardioInsight Technologies acquired to further advance heart mapping technology initially developed at CWRU

--CWRU Press Release July 10, 2015--

Ohio Department of Higher Education Announces Members of I-Corps@Ohio Summer Cohort

--Ohio DOE Press Release July 8, 2015--

Sujana Biotech, a New Biotech Start-up, in Launched by BioMotiv

--BioMotiv Press Release July 1, 2015--

Medtronic Announces Acquisition of CardioInsight Technologies, Developer of Non-Invasive Cardiac Mapping System

--Market Watch June 19, 2015--

Leica Microsystems to Acquire OCT Company Bioptigen

--Bionity June 3, 2015--

TRACON Pharmaceuticals Expands License Agreement and Signs Research Agreement with CWRU

--TRACON Pharma Press Release April 8, 2015--

University Research Budgets Hang in the Balance
--Crain's Cleveland Business October 8, 2012--

Universities Turn to Industry to Fund Research
--StateImpact Ohio (WCPN, WKSU, WOSU, NPR) July 24, 2012--

New CWRU tech transfer chief looks to boost corporate partnerships
--MedCity News April 25, 2012--

Next up for CWRU docs' Alzheimer's drug: trials
--Crain's Cleveland Business April 16, 2012--

State Sees Room for Tech Transfer Growth at Colleges
--Crain's Cleveland Business March 26, 2012--

Who to Watch - Joseph Jankowski
--Crain's Cleveland Business January 16, 2012--

CWRU continues technology transfer leadership in Ohio, according to national survey
--Press Release December 19, 2007--

Bared Bones
--Crain's Cleveland Business December 3, 2007--

CWRU spinoff partners with Medtronic to produce, distribute adult stem cell technology
--Press Release November 8, 2007--

Biotech eyes linking Cleveland, Pittsburgh
--Press Release May 20, 2007--

Region on Par with Peers for Invention Disclosures
--Crain's Cleveland Business May 14, 2007--

Case Study in Tech Transfer
--Press Release May 13, 2007--

CWRU Lands in Top 10 Nationally
--Press Release March 15, 2007--

From Drawing Board To Market
--Plain Dealer Editorial March 15, 2007--

The Clinic and CWRU: Leaders in Licensing
--Plain Dealer March 14, 2007--

Information Transfer
--Crain's Cleveland Business Blog March 13, 2007--

New Companies Cash In On Medical Innovations
--Zanesville Times Recorder March 12, 2007--

Medical Innovations Lead to Surging For-Profit Spinoffs
--JumpStart/Akron Beacon Journal March 11, 2007--

CWRU Grows Heart Healthy Companies from its Research
--Press Release December 28, 2006--

CWRU Licenses Methoxyamine to Tracon
--Press Release October 12, 2006--

State Doesn't Keep The Right Graduates
--Toledo Blade October 1, 2006--

JumpStart Inc. plans to invest $400,000 in FLX Micro
--Crains Cleveland Business September 6, 2006--

CWRU/UHHS Launch Start-up Venture for Innovative Cardiac Care
--Press Release August 22, 2006--

A Tech Transfer Success Story
--Cleveland Plain Dealer July 28, 2006--

CWRU Technology Transfer Reaches New Levels of Performance
--Press Release July 10, 2006--

CWRU Licenses Technology
--Crain's Cleveland Business, April 25, 2006--

CWRU completes licensing agreement with Great Lakes Pharmaceuticals
--Press Release April 24, 2006--